The U.S. currently is the global leader in Life Sciences. Recent projections from RHT Consulting's analysis indicate, however, that, if current trends continue, we are at risk to lose our lead in 2019-2029 in Pharma. In medical device and diagnostics we could lose our leadership position in 15-25 years. In Biotech, we take the lead til the late 2030s. China and India are serious contenders in this race. The U.S. needs to break the mold and create a new standard for performance.